Genscript Biotech Corp
HKEX:1548
Genscript Biotech Corp
Operating Income
Genscript Biotech Corp
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Genscript Biotech Corp
HKEX:1548
|
Operating Income
-$387.4m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Operating Income
¥10.9B
|
CAGR 3-Years
43%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Operating Income
¥1.7B
|
CAGR 3-Years
11%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Operating Income
¥4.1B
|
CAGR 3-Years
36%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Operating Income
¥1.6B
|
CAGR 3-Years
19%
|
CAGR 5-Years
25%
|
CAGR 10-Years
32%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Operating Income
¥190.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Genscript Biotech Corp's Operating Income?
Operating Income
-387.4m
USD
Based on the financial report for Dec 31, 2023, Genscript Biotech Corp's Operating Income amounts to -387.4m USD.
What is Genscript Biotech Corp's Operating Income growth rate?
Operating Income CAGR 3Y
-23%
Over the last year, the Operating Income growth was 10%. The average annual Operating Income growth rates for Genscript Biotech Corp have been -23% over the past three years .